S. Edward Torres's Net Worth

$0

Estimate Recalculated Nov 11, 2024 01:40PM EST

Who is S. Edward Torres

S. Edward Torres does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Receptos, Inc., Protagonist Therapeutics, Inc, Surface Oncology, Inc., Aeglea BioTherapeutics, Inc., AILERON THERAPEUTICS INC, and GLOBEIMMUNE INC.

SEC CIK

S. Edward Torres's CIK is 0001552293

Past Insider Trading and Trends

2015 was S. Edward Torres's most active year for acquiring shares with 2 total transactions. S. Edward Torres's most active month to acquire stocks was the month of June. 2015 was S. Edward Torres's most active year for disposing of shares, totalling 3 transactions. S. Edward Torres's most active month to dispose stocks was the month of July. 2013 saw S. Edward Torres paying a total of $0.00 for 18,800 shares, this is the most they've acquired in one year. In 2015 S. Edward Torres cashed out on 35,600 shares for a total of $5,931,588.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Receptos, Inc.

Investor
Updated Aug 27, 2015
Form 4
-100.00%
-701.16K
$208.90
-$5.93M
Aug 27, 2015
Disposition
Aug 25 - Aug 27
Form 4
-24.84%
-220.00K
$178.99
-$39.38M
Jun 16, 2015
672.96K
Sale
Jun 12 - Jun 16
Form 4
7.40K
Jun 01, 2015
892.96K
Grant
May 28
Form 4
-0.81%
-7.20K
$130.15
-$937.08K
Mar 03, 2015
885.56K
Sale
ScheduledFeb 27
Form 4
-2.87%
-26.40K
$129.95
-$3.43M
Feb 25, 2015
892.76K
Sale
ScheduledFeb 23
Form 4
-4.95%
-47.91K
$128.20
-$6.14M
Feb 24, 2015
919.16K
Sale
ScheduledFeb 20 - Feb 23
Form 4
-9.37%
-100.00K
$61.36
-$6.14M
Sep 24, 2014
967.07K
Sale
Sep 22 - Sep 23
Form 4
-21.94%
-300.00K
$62.76
-$18.83M
Sep 19, 2014
1.07M
Sale
Sep 17 - Sep 19
Form 4
-12.76%
-200.00K
$43.24
-$8.65M
Aug 15, 2014
1.37M
Sale
Aug 13
Form 4
9.40K
Jun 05, 2014
9.40K
Grant
Jun 03
Form 4
-21.30%
-424.07K
$25.26
-$10.71M
May 21, 2014
1.57M
Sale
May 19 - May 21
Form 4
-4.33%
-90.08K
$27.37
-$2.47M
May 16, 2014
1.99M
Sale
May 14 - May 15
Form 3/A
Nov 21, 2013
2.08M
Form 4/A
7.37%
142.86K
$6.73
$13.24M
Nov 21, 2013
2.08M
Purchase
May 14
Form 4
18.80K
Jul 19, 2013
18.80K
Grant
Jul 17
Form 4
-84.91%
-11.71M
$6.73
$13.24M
May 14, 2013
2.08M
Buy-Options
May 14
Form 3
May 08, 2013
114.29K
Showing 17 results

Protagonist Therapeutics, Inc

Investor
Updated Aug 16, 2016
Form 4
-90.45%
-19.88M
$12.00
Aug 16, 2016
2.10M
Buy-Options
Aug 16
Form 3
Aug 10, 2016
Showing 2 results

Surface Oncology, Inc.

Investor
Updated Apr 23, 2018
Form 4
-50.75%
-3.55M
$15.00
Apr 23, 2018
3.45M
Buy-Options
Apr 23
Form 3
Apr 18, 2018
Showing 2 results

Aeglea BioTherapeutics, Inc.

Investor
Updated Apr 06, 2016
Form 3
Apr 06, 2016
57.62K
Showing 1 results

AILERON THERAPEUTICS INC

Investor
Updated Jul 07, 2017
Form 4
-86.96%
-7.30M
$15.00
Jul 07, 2017
1.09M
Buy-Options
Jul 05
Form 3
Jun 28, 2017
Showing 2 results

GLOBEIMMUNE INC

Investor
Updated Mar 21, 2016
Form 4
-9.78%
-26.19K
$1.67
-$43.64K
Mar 21, 2016
241.71K
Sale
Mar 17
Form 4
1.70K
Jul 13, 2015
1.70K
Grant
Jul 09
Form 4/A
1.61K
Jul 15, 2014
1.61K
Options
Jul 08
Form 4
-95.35%
-5.52M
$5.73
$776.76K
Jul 09, 2014
269.51K
Buy-Options
Jul 08
Form 3
Jul 01, 2014
Showing 5 results